全文获取类型
收费全文 | 2183篇 |
免费 | 179篇 |
国内免费 | 5篇 |
专业分类
耳鼻咽喉 | 25篇 |
儿科学 | 77篇 |
妇产科学 | 41篇 |
基础医学 | 332篇 |
口腔科学 | 26篇 |
临床医学 | 254篇 |
内科学 | 481篇 |
皮肤病学 | 20篇 |
神经病学 | 172篇 |
特种医学 | 199篇 |
外科学 | 176篇 |
综合类 | 34篇 |
预防医学 | 197篇 |
眼科学 | 9篇 |
药学 | 214篇 |
肿瘤学 | 110篇 |
出版年
2023年 | 7篇 |
2022年 | 17篇 |
2021年 | 26篇 |
2020年 | 31篇 |
2019年 | 25篇 |
2018年 | 56篇 |
2017年 | 33篇 |
2016年 | 35篇 |
2015年 | 36篇 |
2014年 | 74篇 |
2013年 | 106篇 |
2012年 | 111篇 |
2011年 | 126篇 |
2010年 | 69篇 |
2009年 | 62篇 |
2008年 | 96篇 |
2007年 | 103篇 |
2006年 | 91篇 |
2005年 | 89篇 |
2004年 | 94篇 |
2003年 | 87篇 |
2002年 | 99篇 |
2001年 | 64篇 |
2000年 | 64篇 |
1999年 | 76篇 |
1998年 | 47篇 |
1997年 | 52篇 |
1996年 | 57篇 |
1995年 | 52篇 |
1994年 | 46篇 |
1993年 | 30篇 |
1992年 | 41篇 |
1991年 | 44篇 |
1990年 | 29篇 |
1989年 | 37篇 |
1988年 | 33篇 |
1987年 | 27篇 |
1986年 | 30篇 |
1985年 | 26篇 |
1984年 | 23篇 |
1983年 | 21篇 |
1982年 | 11篇 |
1981年 | 11篇 |
1980年 | 9篇 |
1979年 | 9篇 |
1978年 | 9篇 |
1977年 | 6篇 |
1976年 | 6篇 |
1972年 | 5篇 |
1967年 | 4篇 |
排序方式: 共有2367条查询结果,搜索用时 15 毫秒
1.
2.
3.
Marcel J. Kooy Wouter S. Dessing Esther F. Kroodsma Steven R. J. G. Smits Esther H. Fietje Martine Kruijtbosch Peter A. G. M. De Smet 《Pharmacy World & Science》2007,29(2):81-89
OBJECTIVE: According to a report published by the federation of Dutch patients' associations, patients would like to see a pharmacist, who acts more as a personal adviser. This raised the question, how often Dutch community pharmacists have personal consultations with their patients in daily practice, on which factors this depends, and what kind of topics are discussed during these meetings. SETTING: Community pharmacies in the Netherlands. METHOD: A questionnaire was distributed among 800 randomly selected pharmacies. Questions were restricted to consultations characterized by one-to-one contact, drug therapy related content, and adequate privacy. These consultations were labelled as pharmaceutical consultations in private to distinguish them from other contacts between pharmacists and patients. MAIN OUTCOME MEASURE: Number, content, and character of consultations. RESULTS: 198 (24.8%) community pharmacies responded. The pharmacists provide an average of roughly 1.2 consultations in private per working day. The vast majority of respondents provided face-to-face and telephone consultations (94.4 and 91.9%, respectively), only a minority gave consultations by e-mail (30.8%). These consultations primarily dealt with topics related to medication safety. The mean overall time spent was 290 min per month. A relatively high frequency of personal consultations was significantly associated with the absolute number of full-time equivalent pharmacists in the pharmacy. CONCLUSION: The frequency of pharmaceutical consultations in private is low, but may be improved by reorganisation of the pharmacist's activities. The possibility of personal consultations by e-mail is not yet well-developed. Further research is needed to assess the patient's view of pharmaceutical consultations in private. 相似文献
4.
PC Chamyal A Mehta SL Ojha JR Bhardwaj 《Indian journal of otolaryngology and head and neck surgery》1991,43(1):26-27
Primary tuberculous pathology in nasolpolypi is a rare condition. A case of bilateral ethmoidal polypi with tubercular lesion diagnosed on histopathologlcal examination is being reported and the available relevant literature has been reviewed. 相似文献
5.
A Hennipman J Smits B van Oirschot J C van Houwelingen G Rijksen J P Neyt J A Van Unnik G E Staal 《Tumour biology》1987,8(5):251-263
The activities of hexokinase, phosphofructokinase, aldolase, enolase and pyruvate kinase were studied in breast cancer tissues, in comparison to benign breast disease and normal breast tissues. The enzyme activities in breast cancer were significantly increased compared to normal and benign breast tissues (p less than 0.001). Also the increase in activity in benign disease compared to normal was statistically significant (p less than 0.001). Within the group of benign diseases, fibroadenomas could be distinguished from fibrocystic disease, the former generally showing higher activities compared to the latter (p less than or equal to 0.05). Carcinoma subgroups, classified according to their histology, could not be recognized enzymologically. In addition, isozyme composition of pyruvate kinase and enolase was studied. We did not find a significant shift towards K type pyruvate kinase expression in benign disease compared to normal breast tissues. Also fibroadenomas did not differ from fibrocystic disease. However, the amount of K type pyruvate kinase in carcinomas proved to be significantly higher in comparison to benign disease and normal breast tissues (p less than 0.001). Expression of alpha gamma-enolase in normal breast tissue was virtually absent. In benign disease only a minority of specimens did show the hybrid alpha gamma-enolase. Nearly all carcinomas had alpha gamma-enolase expression and in 20% of the carcinomas gamma gamma-enolase could be detected (so-called neuron-specific enolase). By discriminant analysis, the function giving the best discrimination compared to the histological data was based on natural logarithm aldolase and the total of gamma-enolase subunits. Contrary to expectation, the regulator enzymes of glycolysis; i.e., hexokinase, phosphofructokinase and pyruvate kinase were not included in this discriminant function. The best fit produced a 90% correct classification in both benign and malignant disease. If these findings are confirmed to a larger series, the discrimination is sufficiently strong to form the basis of a clinically useful tool. 相似文献
6.
目的:对临床确诊糖尿病患同时测定血清葡萄糖(Glu)及糖化血清蛋白(GSP)的含量,观察二的关系,以及糖化血清蛋白水平对于评价近期(2—3周)糖尿病患血糖在体内变化的临床意义进行了观察。方法:血清葡萄糖、糖化血清蛋白测定均采用酶法测定。结果:178例糖尿病患Glu、GSP均正常3l例占17.4%;Glu、GSP均增高107例占60.1%;Glu正常、GSP增高15例占8.43%;Glu增高、GSP正常25例占14%。结论:糖化血清蛋白的含量不受即时血糖的影响,二的变化不成比例性,对评价糖尿病患2~3周病情的控制是一项灵敏可靠的指标,尤其对于住院病人的治疗与监控有一定的意义。 相似文献
7.
Joseph Smits 《Langenbeck's archives of surgery / Deutsche Gesellschaft fur Chirurgie》1888,28(3):238-242
Ohne Zusammenfassung 相似文献
8.
David M Spiegel Beverly Farmer Gerard Smits Michel Chonchol 《Journal of renal nutrition》2007,17(6):416-422
OBJECTIVE: This study was designed to evaluate the efficacy of magnesium carbonate as a phosphate binder in hemodialysis patients. DESIGN: This study was a prospective, randomized, open-label trial comparing magnesium carbonate/calcium carbonate versus calcium acetate as a sole phosphate binder. SETTING: This study involved outpatient hemodialysis. PARTICIPANTS: We recruited 30 stable hemodialysis patients without a history of frequent diarrhea. INTERVENTION: After receiving informed consent, we randomized patients 2:1 to magnesium carbonate versus calcium acetate. The dose of each binder was titrated to achieve the Kidney Disease Outcomes Quality Initiative (K/DOQI) phosphate target of <5.5 mg/dL. MAIN OUTCOME MEASURE: The efficacy-phase serum phosphorus concentration and the percentage of patients meeting K-DOQI targets for phosphorus, along with the daily elemental calcium intake, were the primary outcome measures. RESULTS: Magnesium carbonate provided equal control of serum phosphorus (70.6% of the magnebind group and 62.5% of the calcium acetate group had their average serum phosphorus within the K-DOQI target during the efficacy phase), while significantly reducing daily elemental calcium ingestion from phosphate binders (908 +/- 24 vs. 1743 +/- 37 mg/day, P < .0001). CONCLUSION: Magnesium carbonate was generally well-tolerated in this selected patient population, and was effective in controlling serum phosphorus while reducing elemental calcium ingestion. 相似文献
9.
10.